查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786981

肽治疗药的全球市场，规模，占有率，趋势，产业分析报告:各类型，各製造厂商，各给药途径，各合成技术，各用途，各地区 - 市场预测(2025年～2034年)

Peptide Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Type (Generic and Innovative), By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Application, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，全球胜肽类治疗市场规模将达到 3,133.3 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

随着製药和生技公司开发出稳定性、生物利用度和递送机制均有所提升的先进製剂，胜肽类治疗市场正在不断发展。胜肽合成技术和固相製造流程的改进正在降低製造成本并拓展製剂选择。

此外，监管机构正在透过支持性框架促进新型胜肽类药物的审批，进一步加速市场成长。临床管线中肽类产品组合的不断增加以及商业化活动的不断增加，正在推动癌症、代谢性疾病、传染病和罕见疾病治疗领域的市场扩张。

胜肽类治疗市场报告重点

按类型划分，新药领域凭藉其卓越的药理特性以及在治疗肿瘤、代谢和罕见疾病等难治性疾病方面经证实的有效性，在2024年成为市场收入占有率的领导者。

按製造商类型划分，随着生物技术公司和专业开发公司越来越多地与合约研发生产组织 (CDMO) 合作，外包领域发展势头强劲。

按给药途径划分，肠外给药途径在2024年获得了最大的收入占有率，继续保持其作为肽类治疗首选给药方式的地位。

北美凭藉其先进的医疗基础设施、强大的研发能力和完善的报销框架，在全球肽类药物市场占主导地位，2024 年占了 60.21% 的市场占有率。

预计亚太地区胜肽类药物市场在预测期内将达到最快的复合年增长率。这是由于政府对生物製药创新的支持不断增加，以及对国内药物开发的投资不断增加。

全球主要市场参与者包括 Advanced Accelerator Applications SA、阿斯特捷利康公司、拜耳公司、勃林格殷格翰国际有限公司、Bracco Imaging S.p.A.、Cardinal Health, Inc.、Curium Pharma、Eckert & Ziegler SE、F. Hoffmann-La Rochebanth Ltd.、GE HealthJ Technologies Ltd. Holdings, Inc.、礼来公司和 Mallinckrodt plc。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球肽治疗药市场洞察

  • 市场概述
  • 肽治疗药市场力学
    • 促进因素和机会
      • 慢性和代谢性疾病盛行率上升
      • 人口快速老化
    • 限制与挑战
      • 製造成本高
  • PESTEL分析
  • 肽治疗药市场趋势
  • 价值链分析

第5章 全球肽治疗药市场:各类型

  • 主要调查结果
  • 简介
  • 非专利
  • 新药

第6章 全球肽治疗药市场:各厂商类型

  • 主要调查结果
  • 简介
  • 自家公司
  • 外部委託

第7章 全球肽治疗药市场:各给药途径

  • 主要调查结果
  • 简介
  • 非口服途径
  • 口服途径
  • 肺
  • 粘膜
  • 其他

第8章 全球肽治疗药市场:各合成技术

  • 主要调查结果
  • 简介
  • 固相肽合成(SPPS)
  • 重组的DNA技术
  • 混合技术
  • 液相肽合成(LPPS)
  • 其他

第9章 全球肽治疗药市场:各用途

  • 主要调查结果
  • 简介
  • 癌症
  • 代谢障碍
  • 心血管疾病
  • 呼吸疾病
  • 肠胃障碍
  • 感染疾病

第10章 全球肽治疗药市场:各地区

  • 主要调查结果
  • 简介
    • 肽治疗药市场评估:各地区，2020～2034年
  • 北美
    • 北美:各类型，2020～2034年
    • 北美:各製造厂商，2020～2034年
    • 北美:各给药途径，2020～2034年
    • 北美:各合成技术，2020～2034年
    • 北美:各用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型，2020～2034年
    • 欧洲:各製造厂商，2020～2034年
    • 欧洲:各给药途径，2020～2034年
    • 欧洲:各合成技术，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型，2020～2034年
    • 亚太地区:各製造厂商，2020～2034年
    • 亚太地区:各给药途径，2020～2034年
    • 亚太地区:各合成技术，2020～2034年
    • 亚太地区:各用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型，2020～2034年
    • 中东·非洲:各製造厂商，2020～2034年
    • 中东·非洲:各给药途径，2020～2034年
    • 中东·非洲:各合成技术，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各类型，2020～2034年
    • 南美:各製造厂商，2020～2034年
    • 南美:各给药途径，2020～2034年
    • 南美:各合成技术，2020～2034年
    • 南美:各用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 事业扩大·收购分析
    • 事业扩大
    • 收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GSK plc(GlaxoSmithKline plc)
  • Ipsen Pharma
  • Ironwood Pharmaceuticals, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Radius Health, Inc.
  • Sanofi S.A.
Product Code: PM6027

The peptide therapeutics market size is expected to reach USD 313.33 Billion by 2034, according to a new study by Polaris Market Research. The report "Peptide Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Type (Generic and Innovative), By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The peptide therapeutics market is evolving as pharmaceutical and biotechnology companies develop advanced formulations with improved stability, bioavailability, and delivery mechanisms. Growing improvements in peptide synthesis technologies and solid-phase manufacturing processes, lowered the production costs and expanded formulation options.

Additionally, regulatory agencies are facilitating the approval of novel peptide drugs through supportive frameworks, further accelerating the market growth. The growing portfolio of peptide-based products in the clinical pipeline and increasing commercialization activity are boosting market expansion across oncology, metabolic disorders, infectious diseases, and rare therapeutic areas.

Peptide Therapeutics Market Report Highlights

In terms of type, the innovative peptide therapeutics segment emerged as the market leader in revenue share during 2024 due its superior pharmacological properties and proven effectiveness in treating challenging conditions across oncology, metabolic disorders, and rare diseases.

In terms of type of manufacturers, the outsourced manufacturing segment is gaining momentum as biotech firms and specialty developers increasingly partner with CDMOs.

Based on route of administration, the parenteral route segment secured the largest revenue share in 2024, maintaining its position as the preferred delivery method for peptide-based treatments.

North America captured a dominant 60.21% share of the global peptide therapeutics market in 2024 due to the region's cutting-edge healthcare infrastructure, robust research capabilities, and comprehensive medical reimbursement frameworks.

The Asia Pacific peptide therapeutics market is poised to register the fastest CAGR during the forecast period due to increasing governmental support for biopharmaceutical innovation, with investments in domestic drug development.

A few global key market players include Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler SE, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GlaxoSmithKline plc (GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, and Mallinckrodt plc.

Polaris Market Research has segmented the market report on the basis of type, type of manufacturers, route of administration, synthesis technology, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Generic

Innovative

By Type of Manufacturers Outlook (Revenue, USD Billion, 2020-2034)

In-house

Outsourced

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Parenteral Route

Oral Route

Pulmonary

Mucosal

Others

By Synthesis Technology Outlook (Revenue, USD Billion, 2020-2034)

Solid Phase Peptide Synthesis (SPPS)

Recombinant DNA Technology

Hybrid Technology

Liquid-Phase Peptide Synthesis (LPPS)

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Cancer

Metabolic Disorders

Cardiovascular Disorders

Respiratory Disorders

Gastrointestinal Disorders

Infectious Diseases

Pain

Dermatological Disorders

Neurological Disorders

Renal Disorders

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Peptide Therapeutics Market Insights

  • 4.1. Peptide Therapeutics Market - Market Snapshot
  • 4.2. Peptide Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic and Metabolic Diseases
      • 4.2.1.2. Rapid Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Manufacturing Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Peptide Therapeutics Market Trends
  • 4.6. Value Chain Analysis

5. Global Peptide Therapeutics Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Generic
    • 5.3.1. Global Peptide Therapeutics Market, by Generic, by Region, 2020-2034 (USD Billion)
  • 5.4. Innovative
      • 5.4.1.1. Global Peptide Therapeutics Market, by Innovative, by Region, 2020-2034 (USD Billion)

6. Global Peptide Therapeutics Market, by Type of Manufacturers

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • 6.3. In-house
    • 6.3.1. Global Peptide Therapeutics Market, by In-house, by Region, 2020-2034 (USD Billion)
  • 6.4. Outsourced
    • 6.4.1. Global Peptide Therapeutics Market, by Outsourced, by Region, 2020-2034 (USD Billion)

7. Global Peptide Therapeutics Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Parenteral Route
    • 7.3.1. Global Peptide Therapeutics Market, by Parenteral Route, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral Route
    • 7.4.1. Global Peptide Therapeutics Market, by Oral Route, by Region, 2020-2034 (USD Billion)
  • 7.5. Pulmonary
    • 7.5.1. Global Peptide Therapeutics Market, by Pulmonary, by Region, 2020-2034 (USD Billion)
  • 7.6. Mucosal
    • 7.6.1. Global Peptide Therapeutics Market, by Mucosal, by Region, 2020-2034 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Peptide Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Peptide Therapeutics Market, by Synthesis Technology

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • 8.3. Solid Phase Peptide Synthesis (SPPS)
    • 8.3.1. Global Peptide Therapeutics Market, by Solid Phase Peptide Synthesis (SPPS), by Region, 2020-2034 (USD Billion)
  • 8.4. Recombinant DNA Technology
    • 8.4.1. Global Peptide Therapeutics Market, by Recombinant DNA Technology, by Region, 2020-2034 (USD Billion)
  • 8.5. Hybrid Technology
    • 8.5.1. Global Peptide Therapeutics Market, by Hybrid Technology, by Region, 2020-2034 (USD Billion)
  • 8.6. Liquid-Phase Peptide Synthesis (LPPS)
    • 8.6.1. Global Peptide Therapeutics Market, by Liquid-Phase Peptide Synthesis (LPPS), by Region, 2020-2034 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Peptide Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Peptide Therapeutics Market, by Application

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.3. Cancer
    • 9.3.1. Global Peptide Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 9.4. Metabolic Disorders
    • 9.4.1. Global Peptide Therapeutics Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
  • 9.5. Cardiovascular Disorders
    • 9.5.1. Global Peptide Therapeutics Market, by Cardiovascular Disorders, by Region, 2020-2034 (USD Billion)
  • 9.6. Respiratory Disorders
    • 9.6.1. Global Peptide Therapeutics Market, by Respiratory Disorders, by Region, 2020-2034 (USD Billion)
  • 9.7. Gastrointestinal Disorders
    • 9.7.1. Global Peptide Therapeutics Market, by Gastrointestinal Disorders, by Region, 2020-2034 (USD Billion)
  • 9.8. Infectious Diseases
    • 9.8.1. Global Peptide Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)

10. Global Peptide Therapeutics Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Peptide Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Peptide Therapeutics Market - North America
    • 10.3.1. North America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.3.3. North America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.4. North America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.3.5. North America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.3.6. Peptide Therapeutics Market - U.S.
      • 10.3.6.1. U.S.: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.3.7. Peptide Therapeutics Market - Canada
      • 10.3.7.1. Canada: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.4. Peptide Therapeutics Market - Europe
    • 10.4.1. Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.6. Peptide Therapeutics Market - UK
      • 10.4.6.1. UK: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.7. Peptide Therapeutics Market - France
      • 10.4.7.1. France: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.8. Peptide Therapeutics Market - Germany
      • 10.4.8.1. Germany: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.9. Peptide Therapeutics Market - Italy
      • 10.4.9.1. Italy: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.10. Peptide Therapeutics Market - Spain
      • 10.4.10.1. Spain: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.11. Peptide Therapeutics Market - Netherlands
      • 10.4.11.1. Netherlands: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.12. Peptide Therapeutics Market - Russia
      • 10.4.12.1. Russia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.13. Peptide Therapeutics Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.5. Peptide Therapeutics Market - Asia Pacific
    • 10.5.1. Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.6. Peptide Therapeutics Market - China
      • 10.5.6.1. China: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.7. Peptide Therapeutics Market - India
      • 10.5.7.1. India: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.8. Peptide Therapeutics Market - Malaysia
      • 10.5.8.1. Malaysia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.9. Peptide Therapeutics Market - Japan
      • 10.5.9.1. Japan: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.10. Peptide Therapeutics Market - Indonesia
      • 10.5.10.1. Indonesia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.11. Peptide Therapeutics Market - South Korea
      • 10.5.11.1. South Korea: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.12. Peptide Therapeutics Market - Australia
      • 10.5.12.1. Australia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.13. Peptide Therapeutics Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.6. Peptide Therapeutics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.6. Peptide Therapeutics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.7. Peptide Therapeutics Market - UAE
      • 10.6.7.1. UAE: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.8. Peptide Therapeutics Market - Israel
      • 10.6.8.1. Israel: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.9. Peptide Therapeutics Market - South Africa
      • 10.6.9.1. South Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.10. Peptide Therapeutics Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.7. Peptide Therapeutics Market - Latin America
    • 10.7.1. Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.6. Peptide Therapeutics Market - Mexico
      • 10.7.6.1. Mexico: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.7. Peptide Therapeutics Market - Brazil
      • 10.7.7.1. Brazil: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.8. Peptide Therapeutics Market - Argentina
      • 10.7.8.1. Argentina: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.9. Peptide Therapeutics Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Amgen Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. AstraZeneca PLC
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly and Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. F. Hoffmann-La Roche Ltd
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. GSK plc (GlaxoSmithKline plc)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Ipsen Pharma
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Ironwood Pharmaceuticals, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Novartis AG
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Novo Nordisk A/S
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Pfizer Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Radius Health, Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Sanofi S.A.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development

List of Tables:

  • Table 1 Global Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 3 Global Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 5 Global Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 7 North America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 8 North America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 9 North America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 10 North America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 11 U.S.: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 13 U.S.: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 U.S.: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 15 U.S.: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 17 Canada: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 18 Canada: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 19 Canada: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 20 Canada: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 21 Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 23 Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 25 Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 26 UK: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 27 UK: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 28 UK: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 29 UK: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 30 UK: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 31 France: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 32 France: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 33 France: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 France: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 35 France: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Germany: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 37 Germany: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 38 Germany: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 39 Germany: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 40 Germany: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Italy: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Italy: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 43 Italy: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Italy: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 45 Italy: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 46 Spain: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 47 Spain: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 48 Spain: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 49 Spain: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 50 Spain: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Russia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 57 Russia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 58 Russia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 59 Russia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 60 Russia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 71 China: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 72 China: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 73 China: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 China: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 75 China: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 76 India: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 77 India: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 78 India: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 79 India: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 80 India: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 86 Japan: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 87 Japan: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 88 Japan: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 89 Japan: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 90 Japan: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 96 South Korea: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 97 South Korea: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 98 South Korea: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 99 South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 100 South Korea: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Australia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Australia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 103 Australia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Australia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 105 Australia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 121 UAE: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 122 UAE: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 123 UAE: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 UAE: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 125 UAE: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 126 Israel: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 128 Israel: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 129 Israel: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 130 Israel: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 131 South Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 133 South Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 134 South Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 135 South Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 141 Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 142 Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 143 Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 144 Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 145 Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 146 Mexico: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 147 Mexico: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 148 Mexico: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 149 Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 150 Mexico: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 151 Brazil: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 152 Brazil: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 153 Brazil: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 154 Brazil: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 155 Brazil: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 156 Argentina: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 157 Argentina: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 158 Argentina: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 159 Argentina: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 160 Argentina: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Peptide Therapeutics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Peptide Therapeutics Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Type of Manufacturers
  • Figure 9. Global Peptide Therapeutics Market, by Type of Manufacturers, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Peptide Therapeutics Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Synthesis Technology
  • Figure 13. Global Peptide Therapeutics Market, by Synthesis Technology, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Application
  • Figure 15. Global Peptide Therapeutics Market, by Application, 2024 & 2034 (USD Billion)